Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335341 · ClinicalTrials.gov registry record
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
A clinical trial, sponsored by Medtronic Endovascular.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07335341 is a clinical trial that is actively recruiting participants, run by Medtronic Endovascular. The registered enrollment target is 50 participants.
The verdict
NCT07335341 is actively recruiting participants, sponsored by Medtronic Endovascular.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
Interventions
- DEVICE Liberant Thrombectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07335341
The ClinicalTrials.gov registry entry for NCT07335341 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liberant Thrombectomy System is the first listed.
NCT07335341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07335341 about?
NCT07335341 is a clinical study titled "Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System". The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for ...
What is the current status of trial NCT07335341?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-02-24. Estimated completion is 2026-10.
What interventions are being tested in trial NCT07335341?
The interventions under investigation include: Liberant Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT07335341?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.